𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Model for end-stage liver disease, model for end-stage liver disease-sodium and Child–Turcotte–Pugh scores over time for the prediction of complications of liver cirrhosis

✍ Scribed by Pil Cho Choi; Hong Joo Kim; Woo Hyuk Choi; Dong Il Park; Jung Ho Park; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim

Book ID
111237944
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
148 KB
Volume
29
Category
Article
ISSN
0106-9543

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinically relevant differences in the M
Clinically relevant differences in the Model for End-Stage Liver Disease and Model for End-Stage Liver Disease–sodium scores
✍ Rhiana Garritsen; Andrei Tintu; Herold Metselaar; Geert Kazemier 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views

With interest, we read the article by Xiol et al. 1 regarding differences in serum measurements between different laboratories and their influence on the Model for End-Stage Liver Disease (MELD) and the Model for End-Stage Liver Disease incorporating serum sodium (MELD-Na). They reported significant

Reply: Clinically relevant differences i
Reply: Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease–sodium scores
✍ Xavier Xiol; Jose Castellote; Xavier Fuentes-Arderiu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB 👁 1 views

We thank Garritsen et al. 1 for their interest in our article about differences in Model for End-Stage Liver Disease (MELD) and Model for End-Stage Liver Disease-Sodium (MELD-Na) scores determined at 3 different laboratories. 2 We agree that one of the important messages of our article is the import

Model for end-stage liver disease except
Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score–based liver allocation system
✍ Claire Francoz; Jacques Belghiti; Denis Castaing; Olivier Chazouillères; Jean-Ch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 1 views

Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not signific

The model for end-stage liver disease (M
The model for end-stage liver disease (MELD)
✍ Patrick S. Kamath; W. Ray Kim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

The Model for End-stage Liver Disease (MELD) was initially created to predict survival in patients with complications of portal hypertension undergoing elective placement of transjugular intrahepatic portosystemic shunts. The MELD which uses only objective variables was validated subsequently as an